![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Hanner Schlender
hannes.schlender@helmholtz-hzi.de
49-531-618-11400
Helmholtz Association of German Research Centres
Caption: First patient for the clinical trial of "VPM1002."
Credit: Vakzine Projekt Management
Usage Restrictions: None
Related news release: Novel tuberculosis vaccine in Germany in clinical phase
|